DOD Biotech Balance Sheet Health
Financial Health criteria checks 6/6
DOD Biotech has a total shareholder equity of THB1.1B and total debt of THB99.9M, which brings its debt-to-equity ratio to 9.3%. Its total assets and total liabilities are THB1.4B and THB342.8M respectively. DOD Biotech's EBIT is THB50.6M making its interest coverage ratio 6.6. It has cash and short-term investments of THB66.8M.
Key information
9.3%
Debt to equity ratio
฿99.87m
Debt
Interest coverage ratio | 6.6x |
Cash | ฿66.78m |
Equity | ฿1.07b |
Total liabilities | ฿342.75m |
Total assets | ฿1.42b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: DOD's short term assets (THB350.5M) exceed its short term liabilities (THB254.5M).
Long Term Liabilities: DOD's short term assets (THB350.5M) exceed its long term liabilities (THB88.2M).
Debt to Equity History and Analysis
Debt Level: DOD's net debt to equity ratio (3.1%) is considered satisfactory.
Reducing Debt: DOD's debt to equity ratio has reduced from 29.4% to 9.3% over the past 5 years.
Debt Coverage: DOD's debt is well covered by operating cash flow (20.3%).
Interest Coverage: DOD's interest payments on its debt are well covered by EBIT (6.6x coverage).